Rosenberg E S, Billingsley J M, Caliendo A M, Boswell S L, Sax P E, Kalams S A, Walker B D
Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA.
Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447.
Virus-specific CD4+ T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus-type 1 (HIV-1) infection. In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1-specific CD4+ T cell proliferative responses were present, resulting in the elaboration of interferon-gamma and antiviral beta chemokines. In persons with chronic infection, HIV-1-specific proliferative responses to p24 were inversely related to viral load. Strong HIV-1-specific proliferative responses were also detected following treatment of acutely infected persons with potent antiviral therapy. The HIV-1-specific helper cells are likely to be important in immunotherapeutic interventions and vaccine development.
病毒特异性CD4 +辅助性T淋巴细胞对于多种慢性病毒感染中有效免疫的维持至关重要,但在慢性1型人类免疫缺陷病毒(HIV-1)感染中通常检测不到。在未经抗病毒治疗却能控制病毒血症的个体中,存在多克隆、持续性且强烈的HIV-1特异性CD4 + T细胞增殖反应,从而产生γ干扰素和抗病毒β趋化因子。在慢性感染患者中,针对p24的HIV-1特异性增殖反应与病毒载量呈负相关。在用强效抗病毒疗法治疗急性感染患者后,也检测到了强烈的HIV-1特异性增殖反应。HIV-1特异性辅助性T细胞可能在免疫治疗干预和疫苗开发中发挥重要作用。